Product
AboBoNT-A
Aliases
Dysport®
1 clinical trial
1 indication
Indication
Upper Limb SpasticityClinical trial
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport®) in Comparison With OnabotulinumtoxinA (Botox®) When Treating Adults With Upper Limb SpasticityStatus: Recruiting, Estimated PCD: 2025-06-28